Nsun pharma annual report 2012-13 pdf

The directors have pleasure in presentng the 53rd annual report and audited. Filing year any 2020 2019 2018 2017 2016 2015 2014 20 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995. View auditors report of the various companies, comments of auditors, annexure to the auditors report. History 1983 sun pharma established with five psychiatry products and two person marketing team at vapi, gujarat. However, the us and indian formulations are by far the core strengths. This annual report contains forwardlooking statements as defined in the. Notice is hereby given that the 2016 annual meeting of shareholders of sun biopharma, inc.

Information and tools including share price information, dividends, and the latest reports, results and news. Sun pharmaceutical industries limited, also popularly known as sun pharma, is a listed public company. Sun pharma share price, sun pharma stock price, sun. Stockshare prices, sun pharmaceutical industries ltd. Sun pharma advanced research centre s p a r c sun pharma advanced research centre s p a r c 0, tel.

The said integraton has been completed with efect from october 1, 20. Sales were initially limited to 2 states west bengal and bihar. Lead with a range of products expand into new areas l e a p attaining capabilities and strengthening compliance annual report 201819 registered office plot no. This report is primarily an account of the icrcs work in the field and its activities. Sun pharma laboratories limited is an unlisted public company. Sun pharma share price, sun pharma stock price, sun pharmaceutical industries ltd. Sun pharmaceutical s sunp fy17 annual report emphasizes the companys efforts on building its specialty pipeline. Annual report which provides a comprehensive overview of the company for the past year. Statement of changes in beneficial ownership of securities. In 2012, net sales for cummins india limited at rs. Sun pharmaceutical industries ltd annual reports available on tickertape. Download annual report in pdf format 2018 2017 2016 2015 2014 20 2011.

Vesicare, a trademark of astellas pharmaceuticals in. It is an indian multinational pharmaceutical company headquatered in mumbai. Financial information regeneron pharmaceuticals inc. It was incorporated on 01 march, 1993 and is located in vadodara, gujarat. The company manufactures and markets a large basket of pharmaceutical formulations in india, the us and several other markets across the world. Get the detailed quarterly annual income statement for sun pharmaceutical sunpharma. With over 18 manufacturing units, nine research centres and more than 20,000 professionals working globally, we have built a formidable pharmaceutical a global pharmaceutical major.

Corporate information leading global pharmaceutical. Sun pharmaceutical industries detailed director reports covering sun pharma financial results and performance report. The specialty business also represents our important initiative to move up the pharmaceutical value chain and usher in enhanced innovation for our business. Sun pharma consolidated december 2019 net sales at rs 8,154. Sun pharma inds reports, company history, directors. During the fiscal year, sun s shanghvi collected a symbolic salary of rs 1, worth less than 1. Annual report or shall be deemed to be incorporated. Shweta mahadik 110 surendra saroj 111 sushmitha raikar 1 swapnil rajwade 115 trinette dmello 117 valen miranda 119 introduction sunpharmaceuticals sunpharmaceuticals was established in 1983 in vapi with five products to analyze sickness. Sun pharmaceutical industries directors report, sun pharma. Your directors take pleasure in presenting the seventeenth annual report and audited accounts for the year ended 31st march, 2009.

Annual reports archive bausch health companies inc. In our pharmaceuticals business segment, our results included strong growth. Annual report 201819 1 specialty in progress we, at sun pharma, view our specialty business as an additional engine of sustainable growth and cashflows over the long term. Part 1, item 1a, risk factors of our 2012 annual report on form 10k and in the. Annual report 2012 to the members of sun pharmaceutical industries limited report on the financial statements we have audited the accompanying financial statements of sun pharmaceutical industries limited the company, which comprise the balance sheet as at 31st march, 20, the statement of profit and loss and the. Sun pharma inds auditors report of sun pharma inds. Dbgs legacy is one of performance, values and public spiritedness. The company offers formulations in various therapeutic areas, such as cardiology. Annual report 2018 lupin is at the tipping point of its and its destiny heritage. Sunps fy15 annual report analysis highlights 71% yoy increase in revenue to inr274b while ebitda margins declined to 28. Analyse income statement, cashflow statement and balance sheet of sun pharmaceutical industries.

Financial services limited, sun pharmaceutical industries. Annual report 2012 to the members of sun pharmaceutical industries limited report on the financial statements we have audited the accompanying financial statements of sun pharmaceutical industries limited the company, which comprise the balance sheet as at 31st march, 20, the statement of profit and loss and the cash flow statement for the. Patel founder chairman, zydus cadila august 19, 1925 september 19, 2001 it is our founder chairman, the late mr. Established in 1983, sun pharma is the largest indian pharmaceutical company both in terms of market capitalisation and turnover fy15. The displayed data may not be real time due to streaming delays. Sun pharma laboratories limited company information. The company has five directors naresh chand singhal, sailesh trambaklal desai, and others. It was incorporated on 17 january, 1997 and is located in mumbai city, maharashtra.

1328 416 1109 1286 459 658 229 708 103 485 277 79 626 1208 964 40 1157 1250 781 1392 901 437 1255 1058 1315 885 986 145 351 989 606 537 1182 259 1023 4 1225 328 895 1388 995 1302 1466 176 1026 990 1046 995 915